STEMI diagnosis Sample Clauses

STEMI diagnosis. None of the hospitals had chest pain protocols to guide health workers in the diagnosis and manageme of chest pain, TableO2n. availability of ECG and interpretation of the results, none of the hospitals had the capability of performingEaCnG within minuteass recommendeadndinterpretingthe findings. Xxxxxxx Xxxxxxx level 5 Not in place Within 90 minutes Within 3 hours informally Result within 120 minutes Available and can be given within 90 minutes Available and can be given within 90 minutes Not in place Available within 3 hours ECG and hemodynamics monitoring in either ER or ICU/HDU but not in both level Not in place One in hospital Informal processes exist but not formalized Garissa Iftin level 4 Not in place Greater than 3 hours Within 3 hours informally Result within 12 hours Not available Not available Not in place Takes more than 3hrs to access Only one of the above available, but not both, within the ER or HDU level areas Not in place Not in place No process demonstrated Embu Embu level 5 Not in place Within 90 minutes Greater than 3 hours Result within six hours Available and can be given within 90 minutes Not available Not in place Takes more than 3hrs to access ECG and hemodynamics monitoring in either ER or ICU/HDU but not in both level Not in place One in hospital Informal processes exist but not formalized Embu Siakago level 4 Not in place Greater than 3 hours Greater than 3 hours Result within 12 hours Available within 3 hours Not available Not in place Takes more than 3hrs to access Only one of the above available, but not both, within the ER or HDU level areas Not in place Not in place Informal processes exist but not formalized Kiambu Kiambu level 5 Not in place Within 3 hours Within 3 hours informally Result within six hours Available and can be given within 30 minutes Not available Not in place Takes more than three hours to access Only one of the above available, but not both, within the ER or HDU level areas Not in place One in hospital Process depends on person to person referral County Hospital Level of heart attack preparedness based on the 12 elements criteria Chest pain Protocol ECG Availability ECG Interpretation Troponin Testing Aspirin Loading (300mg) Anti- platelet therapy loading Lysis Protocol Thrombo- lysis Monitoring Resuscitatio protocols Defibrillator Referral System Kiambu Kihara level 4 Not in place Within 30 minutes Reported via informal network within 30 minutes Result within six hours Available within 3 hours Not avai...
STEMI diagnosis. None of the hospitals had chest pain protocols to guide health workers in the diagnosis and management of chest pain, Table 2. On availability of ECG and interpretation of the results, none of the hospitals had the capability of performing an ECG within minutes as recommended and interpreting the findings.

Related to STEMI diagnosis

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Diagnostic procedures to aid the Provider in determining required dental treatment.

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in xxxx rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Medical Verification The Town may require medical verification of an employee’s absence if the Town perceives the employee is abusing sick leave or has used an excessive amount of sick leave. The Town may require medical verification of an employee’s absence to verify that the employee is able to return to work with or without restrictions.

  • Medication 1. Xxxxxxx’s physician shall prescribe and monitor adequate dosage levels for each Client. 2. Xxxxxxx’s physician shall not impose and/or limit dosage capitations for any prescribed medication for the treatment of opioid use disorder.

  • Diagnostic Assessment 6.3.1 Boards shall provide a list of pre-approved assessment tools consistent with their Board improvement plan for student achievement and which is compliant with Ministry of Education PPM (PPM 155: Diagnostic Assessment in Support of Student Learning, date of issue January 7, 2013). 6.3.2 Teachers shall use their professional judgment to determine which assessment and/or evaluation tool(s) from the Board list of preapproved assessment tools is applicable, for which student(s), as well as the frequency and timing of the tool. In order to inform their instruction, teachers must utilize diagnostic assessment during the school year.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.